¦~¿Õ¨©º¸¥Í²zÂå¾Ç¼ú T «e¨¥¡G ¦~¿Õ¨©º¸Âå¾Ç¼ú±o¥D¬° Peter C Doherty ¨¯§J¯Ç¦N¡] Rolf M Zinkernagel ¡Aì¦]¬O¤G¦ì¾ÇªÌ©ó ¦~¦b¿D¬w§¢°ö©Ôªº John Curin School of Medical Research T ºÙ¬°¥Dn²ÓM¬Û®e§Üì major histocompatibility antigens) Peter C Doherty ¡i¥ª¡j ¨¯§J¯Ç¦N¡] Rolf M Zinkernagel ¡^¡i¥k¡j ¤º®e¡G ¦b T ²ÓM©M B ²ÓM¡A¨ä¤¤ B ²ÓM²£¥Íªº§ÜÅé¯à¿ëѤήø·À²Óµß¤§þªº·L¥Íª«¡A¦ý¬O T T ²ÓM©M²¾´Ó¾¹©xªº¥Dn²Õ´¬Û®e§Üì¡] major histocompatibility antigens T ²ÓM¦p¦ó«OÅ@¹êÅç¤p¹«¹ï§Ü¤@ºØ¸£½¤ª¢¯f¬r¡] lymphocytic choriomeningitis virus, LCMV T ²ÓM¡] cytotoxic T cells T ¹Ï¤G ¹êÅç¤èªk»P¨BÆJ¡] ¹Ï¤T T killer cell (upper right) attaching to and sensing the antigens on a target cell µ²½×¡G ¦b B ²ÓM¡B T T ²ÓM¬Ý¡A¬OµLªk¨ë¿E»²§U T ²ÓM¡A¦ÓY»²§U T ²ÓM¨S¦³¨ü¨ë¿E¦Ó¤Àªc¦UºØ¤£¦Pªº²ÓM¿E¯À¡A B ¥Ñ©ó³o¨Ç²z½×Æ[©Àªº«Ø¥ß¡A ¨Ï±o§Ú̹ï²ÓM§K¬Ìªº¯S²§©Ê¦³§ó¶i¤@¨BªºÁA¸Ñ¡A¨ ·P·Q¡G ¬Ý§¹³o½g paper ¡AÅý§Úª¾¹D T ²ÓM¿ëÑ¥~¨Ó§Ü쪺¾÷¨î©M B ¸É¥R¸ê®Æ¡G §ÜÀù§K¬Ì¤ÏÀ³¥i¯à¨ú¨M©ó¸~½F§Üì¦ó®É¡B¦ó³B§Î¦¨ ·sªº¬ã¨s¤ä´© ¤£¦P T ²ÓM§ÜÀù¾÷¨î°ò©óÀù²ÓMµo®i¦´Áªº¦ì¸m©M©Ê½è ¡C ¨¯§J¯Ç¦N¡] Rolf M Zinkernagel ³Õ¤h©M¦P¨Æ¶i¦æ¤F¤@¨t¦C¹êÅç¡A·QnÄÄ©ú¾÷Åé¹ï¤£¦P¸~½Fªº§K¬Ì¤ÏÀ³¡C¬ã¨sªÌ¦bªñ´Á¡m¦ÛµM¡n¡] Nature ¡^¤Wµoªí³ø§iºÙ¡A¦b²O¤Ú²ÓM¥Í¦¨¨t²Î¤§¤ºµo®iªº¸~½F¤Þ°_²ÓM¬r T ²O¤Ú²ÓM¡] CTL ¡^¤ÏÀ³¡AµM¦Ó¨î¦b¶g䪺¸~½F¤£³o¼Ë¡C¦Ó¥B¡A¸g·Ó®gªºµu¹ØÀù²ÓM¦³®Äªº¦bµÊ¤º°Êû¦ÛµM | |
|